Lupin Digital Health reveals results of digital therapeutics study with ACS patients
The one-year-long study was aimed to evaluate the efficacy of LDH's digital therapeutics platform
The one-year-long study was aimed to evaluate the efficacy of LDH's digital therapeutics platform
This is especially the case if the patients are young, have multiple blocks & have conditions that may make angioplasty to implant drug-eluting stents ineffective
Patients will no longer need to travel abroad for treatment of acute cardiac diseases
Amala Hospital partners with LifeSigns to provide revolutionary technology for the first time in the State
Profit after Tax stood at Rs. 106 crore as compared to Rs. 84 crore registering growth of 26%
Medical Tourism will boost India’s economy
Sacu V is priced at Rs. 19 per tablet for a dose of 50 mg (sacubitril 24 mg + valsartan 26 mg)
Moderna and Merck announced mRNA-4157/V940, in combination with KEYTRUDA, demonstrated a 44% reduction in the risk of disease recurrence or death in melanoma patients
Upon approval, XPHOZAH would be the first and only phosphate absorption inhibitor, offering patients a novel mechanism
Subscribe To Our Newsletter & Stay Updated